News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
72 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (7)
2 (15)
3 (243)
4 (292)
5 (235)
6 (83)
7 (4)
8 (20)
9 (229)
10 (249)
11 (163)
12 (210)
13 (72)
14 (2)
15 (29)
16 (196)
17 (228)
18 (224)
19 (189)
20 (95)
21 (7)
22 (4)
23 (193)
24 (210)
25 (262)
26 (241)
27 (78)
28 (20)
29 (55)
30 (184)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Deals
10x Genomics CEO Calls IPO a Validation of the Company’s Years-Long Strategy
Shares of 10X Genomics surged more than 35% on its first day of trading to close at $52.75, well above its $39 initial price offering starting point.
September 13, 2019
·
2 min read
·
Alex Keown
Drug Development
Clinical Catch-Up: September 9-13
Last week was a busy one for clinical trial results, particularly with the European Committee for Treatment and Research in Multiple Sclerosis 2019 Congress going on. Here’s a look at some of the top clinical trial stories.
September 13, 2019
·
11 min read
·
Mark Terry
Drug Development
Biogen and Eisai Abandon BACE Inhibitor Program in Alzheimer’s Disease
The Data Safety Monitoring Board ran a safety review and recommended the trials end because of an unfavorable risk-benefit ratio.
September 13, 2019
·
3 min read
·
Mark Terry
Policy
FDA Action Alert: Merck and Amarin
September has been a relatively slow month for the U.S. Food and Drug Administration. However, there are two PDFUA dates remaining, although one of those took an unexpected turn that will delay it until later in the year.
September 13, 2019
·
3 min read
·
Mark Terry
Career Advice
4 Job Description Buzz Words and What They Really Mean
These words are used frequently for a reason. But what are companies really getting at with these job description buzz words?
September 13, 2019
·
2 min read
·
Laura Brothers
FDA
FDA Approves GSK’s Nucala for Children with Severe Eosinophilic Asthma
Nucala is the only targeted biologic to be approved for the condition in the six to 11-year age group in the United States, the company said.
September 13, 2019
·
2 min read
·
Alex Keown
Circular RNA Found to Stimulate Cancer Progression
Researchers have recently identified a circRNA that increases activity in soft tissue and connective tissue tumors.
September 13, 2019
·
2 min read
·
Mark Terry
Biotech Beach
Novartis Offers Online Educational Programs to All Employees Via Coursera
The biopharma company will utilize Coursera’s enterprise platform, Coursera for Business, to offer educational programs to its 108,000 staffers around the world.
September 13, 2019
·
3 min read
·
Mark Terry
From Mentor to Sponsor: Enlisting Others to Help Boost Your Life Sciences Career
Career experts advocate having both a mentor and a sponsor.
September 13, 2019
·
4 min read
·
Katharine Hansen, PhD
Drug Development
Genentech’s Fixed Dose Subcutaneous Combination of Perjeta and Herceptin Showed Non-Inferiority When Compared to Intravenous Formulations for People With HER2-Positive Breast Cancer
Genentech, a member of the Roche Group, announced the Phase III FeDeriCa study met its primary endpoint.
September 13, 2019
·
13 min read
1 of 8
Next